The total amount of review has reached 436 and passed another batch: metformin, Cefalexin

Source: announcement of listed pharmaceutical companies ▍ finishing: Cypress blue corn Another batch of drugs has been evaluated, and the total number has reached 436 On November 28, the State Council held a regular briefing on the policy of further deepening medical reform through centralized drug purchase and use, which revealed that the document to be published: some policy measures on further deepening the reform of medical and health system through centralized drug purchase and use, which will actively promote the consistency evaluation of quality and efficacy of generic drugs It was announced at the meeting that up to now, a total of 123 varieties, including 323 specifications, have passed the consistency evaluation 66 varieties of generic drugs approved according to the same standard as the original research, including 113 product specifications There are 184 varieties in total, including 436 specifications As the State Council said, at present, the consistency evaluation of generic drugs has entered the normal state It can be seen from the announcement issued by monitoring listed pharmaceutical companies that the density and speed of drug over evaluation are increasing Recently, some drugs have passed the consistency evaluation On November 28, Shijiazhuang Yiling Pharmaceutical Co., Ltd issued the announcement on the conformity evaluation of metformin hydrochloride tablets It recently received the approval document for supplementary application of metformin hydrochloride tablets (0.25g) approved and issued by the State Food and drug administration The drug passed the conformity evaluation of quality and efficacy of generic drugs According to the data, metformin hydrochloride tablets are oral hypoglycemic drugs of biguanide type, which are widely used in the population They belong to category A (2019 version) of the national medical insurance catalogue and category of essential drugs (2018 version) At present, a total of 15 domestic product specifications have passed the consistency evaluation of metformin hydrochloride tablets On November 27, Sichuan Kelun Pharmaceutical Co., Ltd issued the notice on the conformity evaluation of amoxicillin granules passing generic drugs, and its subsidiary Hunan Kelun Pharmaceutical Co., Ltd passed the conformity evaluation of amoxicillin granules (0.125g (calculated according to c16h19n3o5s)) At present, amoxicillin has capsules, tablets, granules, dispersible tablets and other dosage forms in China, amoxicillin granules are more suitable for children and patients with dysphagia, and has entered the category a medical insurance and the national basic drug catalog in 2018 Previously, amoxicillin capsule (0.25g) from Kerun, Hunan Province has been evaluated On November 27, Chongqing Taiji industry (Group) Co., Ltd issued the announcement on the conformity evaluation of isoniazid tablets of the company through generic drugs Its holding subsidiary Southwest Pharmaceutical Co., Ltd received the approval document for supplementary application of isoniazid tablets (100mg tablets) from the State Drug Administration and passed the conformity evaluation According to the data, the original preparation of isoniazid tablets was launched in November 1952, and the manufacturer was sandozinc Up to now, according to the database statistics of the State Food and drug administration, 379 domestic enterprises have the production approval documents of the product, and 5 have passed the consistency evaluation In 2018, the total sales volume of the drug in public hospitals of cities above prefecture level in China is about 76.79 million yuan; in retail pharmacies of cities above prefecture level in China, the total sales volume of county-level public hospitals, urban community hospitals and township health hospitals is about 12 million yuan (the above data source is menet database).